MedTrace Logo

Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing Patients

NCT03466086 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2019-06-28

Study results available
· View outcomes & findings →

Summary

This clinical study is a randomized, double-masked, cross-over, bilateral, 2 treatment x 2 period, dispensing 4-visit study with a 7-9 day washout period in between visits 2 and 3. The study will last approximately 3 months.

Conditions

  • Visual Acuity

Interventions

DEVICE

Test Eye Drops

blink® intensive TRIPLE ACTION 3 in 1 eye drops

DEVICE

Control Eye Drops

Systane® BALANCE eye drops

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-09
Primary Completion
2018-05-16
Completion
2018-05-16
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03466086 on ClinicalTrials.gov